Abstract
In recent years our appreciation of the function and design of many signalling pathways implicated in cancer has changed substantially. The original idea of intrinsically independent and linear routes has progressively evolved to the concept of complex networks, involving extensive crosstalk and interplay between various signalling pathways. Yet, we are only beginning to understand how these networks are interconnected within cancer cells. This knowledge will be essential for the design of effective drug combinations as well as for the anticipation of potential mechanisms of resistance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
